These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21199605)

  • 1. Cutaneous melanoma: Taiwan experience and literature review.
    Chang JW
    Chang Gung Med J; 2010; 33(6):602-12. PubMed ID: 21199605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma in children and the use of sentinel lymph node biopsy.
    Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
    J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
    Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
    J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM
    Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
    Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
    Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of malignant melanoma.
    Essner R
    Surg Clin North Am; 2003 Feb; 83(1):109-56. PubMed ID: 12691453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms.
    Faries MB; Bleicher RJ; Ye X; Essner R; Morton DL
    Arch Surg; 2004 Aug; 139(8):870-6; discussion 876-7. PubMed ID: 15302697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multicenter, retrospective study of 291 Japanese patients.
    Fujisawa Y; Otsuka F;
    Melanoma Res; 2012 Oct; 22(5):362-7. PubMed ID: 22713797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surgical and adjuvant drug therapy in head and neck cutaneous melanoma].
    Hauschild A; Lischner S; Christophers E
    Laryngorhinootologie; 2000 Jul; 79(7):428-33. PubMed ID: 11005097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy.
    Zapas JL; Coley HC; Beam SL; Brown SD; Jablonski KA; Elias EG
    J Am Coll Surg; 2003 Sep; 197(3):403-7. PubMed ID: 12946795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vulvar melanoma: is there a role for sentinel lymph node biopsy?
    de Hullu JA; Hollema H; Hoekstra HJ; Piers DA; Mourits MJ; Aalders JG; van der Zee AG
    Cancer; 2002 Jan; 94(2):486-91. PubMed ID: 11905414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma.
    Ghaferi AA; Wong SL; Johnson TM; Lowe L; Chang AE; Cimmino VM; Bradford CR; Rees RS; Sabel MS
    Ann Surg Oncol; 2009 Nov; 16(11):2978-84. PubMed ID: 19711133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in the management of patients with melanoma.
    Lang PG
    Am J Clin Dermatol; 2002; 3(6):401-26. PubMed ID: 12113649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathobiology of the sentinel node.
    Cochran AJ; Ohsie SJ; Binder SW
    Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.